Results 211 to 220 of about 3,066,509 (354)
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Comparison of acid and hydrothermal pretreatments of date waste for value creation. [PDF]
Oladzad S +5 more
europepmc +1 more source
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Encourage or Reject Employee Involvement: Value Creation in Human Resource Management in the AI Era-An Evolutionary Game Analysis of Enterprises and Employees. [PDF]
Yang X, Yan S.
europepmc +1 more source
Who counts when health counts? A case-study of multi-stakeholder initiative to promote value-creation in Swedish healthcare. [PDF]
Tragl L +3 more
europepmc +1 more source
Value Creation through Corporate Social Responsibility: A Quantitative ABCD Analysis
Steevan D Souza N., K.V.M. Varambally
openalex +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Psychosocial factors contributing to value creation in value-based healthcare: a scoping review. [PDF]
Marino L, Capone V.
europepmc +1 more source

